Department of Surgery, Medicine, Molecular Biology and Critical Care, University of Pisa, Italy.
Pulmonary Unit, Nuovo Ospedale Apuano, Massa, Italy.
Respir Med. 2021 Dec;190:106672. doi: 10.1016/j.rmed.2021.106672. Epub 2021 Oct 28.
Sputum eosinophilia in Chronic Obstructive Pulmonary Disease (COPD) patients seems to be associated with a better response to inhaled corticosteroids (ICS). To verify if this feature could identify a specific subpopulation of COPD patients, we retrospectively compared functional and inflammatory parameters of 110 COPD patients according to the presence of sputum eosinophilia (>2%). Patient with eosinophilia were characterized by lower dyspnea score, lower functional impairment and lower ICS use, suggesting that airway eosinophilia may be associated to a lower COPD severity and some functional "asthma-like" characteristics, therefore explaining the better response to ICS in this subgroup of patients.
慢性阻塞性肺疾病(COPD)患者的痰嗜酸性粒细胞似乎与吸入皮质类固醇(ICS)的更好反应相关。为了验证这一特征是否可以识别 COPD 患者的特定亚群,我们根据痰嗜酸性粒细胞(>2%)的存在,回顾性比较了 110 例 COPD 患者的功能和炎症参数。嗜酸性粒细胞患者的呼吸困难评分较低,功能障碍程度较低,ICS 使用较少,这表明气道嗜酸性粒细胞可能与 COPD 严重程度较低和某些功能“哮喘样”特征相关,因此可以解释该亚组患者对 ICS 的更好反应。